Peer-influenced content. Sources you trust. No registration required. This is HCN.
News Medical
Methylene blue’s ability to penetrate the blood-brain barrier while reducing oxidative stress and promoting Nrf2 expression presents a novel therapeutic pathway for neurodegenerative disorders that warrants further investigation despite limited clinical evidence.
Emergency Medicine April 30th 2025